Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Tap

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
The Lancet. Oncology|September 9, 2017
GeDDiS: insight into frontline therapy in soft tissue sarcomaWilliam D Tap
The Lancet. Oncology|April 29, 2019
Multidisciplinary care in tenosynovial giant cell tumoursWilliam D Tap
Lancet (London, England)|December 15, 2022
Towards a new era in the treatment of Ewing sarcomaEmily K Slotkin, William D Tap
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
That's the "GIST" of it: use of adjuvant imatinib after resection of a primary GI stromal tumorWilliam D Tap, Gary K Schwartz
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 11, 2022
Role of colony-stimulating factor 1 in the neoplastic process of tenosynovial giant cell tumorWilliam D Tap, John H Healey
The Lancet. Oncology|September 16, 2018
TOMAS: revisiting PARP inhibitor combination therapyBenjamin A Nacev, William D Tap
Expert Review of Anticancer Therapy|October 27, 2012
Clinical trial end points for assessing efficacy of novel therapies for soft-tissue sarcomasBartosz Chmielowski, Noah Federman, William D Tap
Immunotherapy|August 4, 2016
Current status of engineered T-cell therapy for synovial sarcomaMatthew Dallos, William D Tap, Sandra P D'Angelo
Expert Review of Anticancer Therapy|May 12, 2007
Targeted therapies for soft-tissue sarcomasWilliam D Tap, Noah Federman, Fritz C Eilber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Locally Aggressive Connective Tissue TumorsMrinal M Gounder, David M Thomas, William D Tap
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
The Lancet. Oncology|September 9, 2017
GeDDiS: insight into frontline therapy in soft tissue sarcomaWilliam D Tap
The Lancet. Oncology|April 29, 2019
Multidisciplinary care in tenosynovial giant cell tumoursWilliam D Tap
Lancet (London, England)|December 15, 2022
Towards a new era in the treatment of Ewing sarcomaEmily K Slotkin, William D Tap
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
That's the "GIST" of it: use of adjuvant imatinib after resection of a primary GI stromal tumorWilliam D Tap, Gary K Schwartz
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 11, 2022
Role of colony-stimulating factor 1 in the neoplastic process of tenosynovial giant cell tumorWilliam D Tap, John H Healey
The Lancet. Oncology|September 16, 2018
TOMAS: revisiting PARP inhibitor combination therapyBenjamin A Nacev, William D Tap
Expert Review of Anticancer Therapy|October 27, 2012
Clinical trial end points for assessing efficacy of novel therapies for soft-tissue sarcomasBartosz Chmielowski, Noah Federman, William D Tap
Immunotherapy|August 4, 2016
Current status of engineered T-cell therapy for synovial sarcomaMatthew Dallos, William D Tap, Sandra P D'Angelo
Expert Review of Anticancer Therapy|May 12, 2007
Targeted therapies for soft-tissue sarcomasWilliam D Tap, Noah Federman, Fritz C Eilber
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Locally Aggressive Connective Tissue TumorsMrinal M Gounder, David M Thomas, William D Tap
Pageof 22